Clear Path Psychiatry

Clear Path Psychiatry in Seattle, Washington offers Spravato esketamine for patients with difficult-to-treat or treatment-resistant depression, including those who may be suicidal. Spravato can provide relief within hours, working differently from typical antidepressants by modulating glutamate to calm the brain's default mode network, which drives anxious, self-critical, and ruminative thoughts.

Spravato is self-administered as a nasal spray in the office under close supervision, with monitoring for at least two hours. Treatment is given twice a week for the first four weeks, then every one to two weeks if effective.

The practice also offers TMS, and many patients start with Spravato for rapid relief before switching to TMS for longer-lasting results. Clear Path Psychiatry takes an integrative, patient-centered approach to depression, anxiety, and OCD.